Evidence map›Paper›PMID 40845190›Full record

ArticleInflammatory bowel diseases2025

Bacterial Dysbiosis Observed in the Terminal Ileum of Ulcerative Colitis.

Jordan S Mar, Allen Nguyen, Alexis Scherl, May Wittke, Mary Doona, Christopher A Lamb, Mary E Keir

Abstract read
In one paragraph

Article in Inflammatory bowel diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jordan S MarGenentech Research & Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, United States.ORCID 0000-0002-0060-802X
Allen NguyenGenentech Research & Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, United States.
Alexis ScherlGenentech Research & Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, United States.
May WittkeGenentech Research & Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, United States.
Mary DoonaDepartment of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, United Kingdom.
Christopher A LambDepartment of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, United Kingdom.
Mary E KeirGenentech Research & Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, United States.

Funding

AstraZenecaGenentech Inc.Medical Research CouncilNewcastle Biomedical Research CentreNIHRWellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40845190
PMCPMC12638054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.